Thu, Nov 21, 2024
| فارسی
Volume 26, Issue 4 (Winter 2021)
IJPCP 2021, 26(4): 418-431 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shareh H, Robati Z. Effect of Cognitive-Behavioral Group Therapy on Pain Self-efficacy, Fatigue, Life Expectancy and Depression in Patients With Multiple Sclerosis: A Randomized Controlled Clinical Trial. IJPCP 2021; 26 (4) :418-431
URL: http://ijpcp.iums.ac.ir/article-1-3065-en.html
URL: http://ijpcp.iums.ac.ir/article-1-3065-en.html
1- Department of Educational Sciences, Faculty of Letters and Humanities, Hakim Sabzevari University, Sabzevar, Iran. , h.shareh@hsu.ac.ir
2- Department of Clinical Psychology, Faculty of Psychology and Educational Sciences, Semnan University, Semnan, Iran.
2- Department of Clinical Psychology, Faculty of Psychology and Educational Sciences, Semnan University, Semnan, Iran.
Abstract: (4866 Views)
Objectives: The present study aims to investigate the effect of Cognitive-Behavioral Group Therapy (CBGT) on pain self-efficacy, fatigue, life expectancy and depression in patients with Multiple Sclerosis (MS).
Methods: In this quasi-experimental clinical trial with a pretest/posttest design, 68 patients with MS referred to MS clinics and MS Association of Razavi Khorasan Province, Iran were selected using a convenience sampling technique, and were then assigned into intervention and control groups. The intervention group received ten 2-hour weekly sessions of CBGT, while the control group received no treatment. In the pretest and posttest phases, Pain Self-Efficacy Questionnaire (PSEQ), Fatigue Severity Scale (FSS), Snyder’s Adult Hope Scale (AHS) and Beck Depression Inventory-Second Edition (BDI-II) were completed by all subjects. The collected data were analyzed using ANCOVA and t-test.
Results: The CBGT significantly improved pain self-efficacy (P=0.001) and life expectancy (P=0.001) and reduced fatigue (P=0.02) and depression (P=0.003) in the intervention group compared to the control group.
Conclusion: CBGT can increase pain self-efficacy, life expectancy and reduce fatigue and depression in patients with MS.
Methods: In this quasi-experimental clinical trial with a pretest/posttest design, 68 patients with MS referred to MS clinics and MS Association of Razavi Khorasan Province, Iran were selected using a convenience sampling technique, and were then assigned into intervention and control groups. The intervention group received ten 2-hour weekly sessions of CBGT, while the control group received no treatment. In the pretest and posttest phases, Pain Self-Efficacy Questionnaire (PSEQ), Fatigue Severity Scale (FSS), Snyder’s Adult Hope Scale (AHS) and Beck Depression Inventory-Second Edition (BDI-II) were completed by all subjects. The collected data were analyzed using ANCOVA and t-test.
Results: The CBGT significantly improved pain self-efficacy (P=0.001) and life expectancy (P=0.001) and reduced fatigue (P=0.02) and depression (P=0.003) in the intervention group compared to the control group.
Conclusion: CBGT can increase pain self-efficacy, life expectancy and reduce fatigue and depression in patients with MS.
Keywords: Multiple Sclerosis, Cognitive-behavioral therapy, Pain self-efficacy, Fatigue, Life expectancy, Depression
Type of Study: Original Research |
Subject:
Psychiatry and Psychology
Received: 2019/08/13 | Accepted: 2020/01/13 | Published: 2021/01/1
Received: 2019/08/13 | Accepted: 2020/01/13 | Published: 2021/01/1
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright © The Author(s);
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
